This chapter explores the origins of the drug Ozempic and its function as a GLP one agonist. It discusses the history of GLP one and the role of the Gila monster lizard in its discovery. It also highlights the benefits of GLP one agonists for individuals with diabetes.
Ozempic is being hailed as “the end of the Obesity Epidemic.” This week, Mike and Aubrey dig through the sensational claims. But will they make it past the caveats?